疼痛

痛 み は 通常, 実 際 も し く は 潜在 的 な 組織 損傷 に 関 連 す る 不快 な 感 覚 的 お よ び 感情 的 な 経 験 と し て 定義 さ れ, 傷害 を 防 ぐ 重要 な メ カ ニ ズ ム と し て 役 立 っ て い ま す. 痛 み の 感 覚 は, 末梢 か ら の 入 力 に 対 す る 脳 の応 答 と し て 生 じ ま す. 傷害, 病 気 ま た は 身体 の 損傷 の た め に 現 れ る 電 気 的 お よ び 化学 的 変 化 は, 多数 の イ オ ン チ ャ ネ ル に よ っ て 中枢 へ 伝 達 さ れ ま す. こ れ ら に 関 わ る イ オ ン チ ャ ネ ル の 役 割 に は, 刺激 を 開始 す る も の, 電 気 的 に 伝 導 す る も の と, シ ナ プ ス を 介 し て 化学 的 に 伝 達 す る も の な ど が あ り ま す.

 

疼痛 に は, 神 経 因 性 (神 経 損傷) 疼痛 と 侵害 受 容性 (組織) 痛 の 2 つ の 基本 的 な タ イ プ が あ り ま す.

神 経 因 性 疼痛 は, 神 経 系 の 原 発 損傷 ま た は 機能 不全 に よ り 引 き 起 こ さ れ, 損傷 組織 の 治癒 後 も 長 く 持 続 し, 慢性 疼痛 に 変 わ る 可能性 が あ り ま す. 侵害 受 容性 疼痛 は, 侵害 受 容器 が 損傷 ま た は 炎症を 起 こ し た 組織 に よ っ て 刺激 さ れ た 場合 に 生 じ ま す. 痛 み は 通常 時間 が 限 ら れ て お り, 身体 を 保護 す る 目的 で 伝 え ら れ ま す.

 

痛みに関与するイオンチャネルについては多くの事例があり,それぞれのイオンチャネルが異なる役割を果たすことが示されてきました.電位依存性Na +チャネルは,求心性神経線維に沿った伝導にとって重要であり,電位依存性Ca 2+チャネルは,シナプス間隙における神経伝達物質の放出に重要な役割を果たします.またForbigående receptor potentialチャネル(TRP), Acid-sensingイオンチャネル(ASIC),グルタミン酸受容体(KA , NMDAおよびAMPAリガンド依存性イオンチャネル)などは,皮下に存在する自由神経終末での一次侵害受容応答に関与します.

Klik for at se større billede

 

 

 

痛 覚 の 感受 お よ び 伝 達 に 関 与 す る イ オ ン チ ャ ネ ル:

 

Key Pain Ion Channels

Na v 1,1, 1,6, 1,7 og 1,8 (1,3 efter skade)
Ca v 1,2, 2,2
TRP
P2X
NMDA, AMPA og KA
ASIC1-3

 

 


Nav1.1, 1.3, 1,4, 1.6, 1.7 & 1.8

Posters

  • 詳細 Multi-parameter ion channel screening: mechanism-of-action data directly from HTS
    Year: 2019 First author: Kammonen et Al., 2019
  • 詳細 Biophysical and pharmacological characterization of multiple Nav subtypes on Qube
    Year: 2016 First author: Lindqvist et Al
  • 詳細 CHO-hNav1.7 assay on Qube pharmacology, biophysical characterization and the effect of internal fluoride
    Year: 2017 First author: Sauter et al., 2017
  • 詳細 Sophion analyzer as a tool for biophysical and pharmacological characterization of eight Nav subtypes evaluated in parallel on Qube
    Year: 2016 First author: Korsgaard et al., 2016
  • 詳細 Biophysical and pharmacological profiling of multiple Nav subtypes on QPatch HT
    Year: 2016 First author: Lindqvist et al., 2016
  • 詳細 “Clip Detecting” with series resistance compensation using an automated patch clamp system
    Year: 2012 First author: Løjkner et al., 2012
  • A small molecule activator of Nav1.1 channels increases fast-spiking interneuron excitability and GABAergic transmission in vitro and has anti-convulsive effects in vivo
    Year: 2017 First author: K Frederiksen

Papers

  • 詳細 Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain
    Year: 2018 First author: Bankar et Al.
  • 詳細 The sodium channel activator Lu AE98134 normalizes the altered firing properties of fast spiking interneurons in Dlx5/6+/− mice
    Year: 2017
  • 詳細 High-Throughput Screening of Nav1.7 Modulators Using a Giga-Seal Automated Patch Clamp Instrument
    Year: 2016 First author: Chambers et al., 2016
  • 詳細 Identification and Electrophysiological Evaluation of 2-Methylbenzamide Derivatives as Nav1.1 Modulators
    Year: 2015 First author: Crestey et al., 2015
  • 詳細 Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening
    Year: 2016 First author: Rogers et al., 2016
  • 詳細 Engineering Highly Potent and Selective Microproteins Against Nav1.7 Sodium Channel for Treatment of Pain
    Year: 2016 First author: Shcherbatko et al., 2016
  • 詳細 Rational engineering defines a molecular switch that is essential for activity of spider-venom peptides against the analgesics target Nav1.7
    Year: 2015 First author: Klint et al., 2015
  • 詳細 Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia
    Year: 2017 First author: Bell

Reports

  • Nav1.1 currents on Qube
    Year: 2018 First author: Klint et Al.
  • 詳細 High throughput screening for mode-of-action on Nav1.4
    Year: 2017 First author: Sauter

Cav1.2

Posters

  • 詳細 Qube as a tool for assay optimization of CiPA cells and protocols by using multiple IC, EC solutions and hERG, Nav1.5 and Cav1.2 on the same QChip
    Year: 2016 First author: Schupp et al., 2016
  • 詳細 Exploring stem cell-derived cardiomyocytes with automated patch clamp techniques
    Year: 2012 First author: Schrøder et al., 2012

Papers

  • 詳細 A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessment
    Year: 2015 First author: Mistry et al., 2015
  • 詳細 Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator
    Year: 2015 First author: Okada et al., 2015
  • 詳細 MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
    Year: 2013 First author: Kramer et al., 2013

Reports

  • 詳細 hCav1.2 recordings on Qube 384 using step, train and CiPA protocols
    Year: 2018 First author: Schupp
  • 詳細 Cav1.2 on Qube 384
    Year: 2017 First author: Schupp, M
  • 詳細 CHO Cav1.2 on QPatch (ChanTest)
    Year: 2011 First author: Friis et al., 2011
  • 詳細 Cor.At cells embryonic stem cell derived cardiomyocytes on QPatch
    Year: 2009 First author: Schrøder et al., 2009

Cav2.2

Papers

  • 詳細 Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of pain
    Year: 2018 First author: Wall et Al., 2018

TRP

Posters

  • 詳細 TRP’ing in multi-hole mode
    Year: 2010 First author: Jacobsen et al., 2010

Papers

  • 詳細 The development of automated patch clamp assays for canonical transient receptor potential channels TRPC3, 6, and 7
    Year: 2014 First author: McPate et Al.
  • 詳細 Study of TRP Channels by Automated Patch Clamp Systems
    Year: 2010 First author: Sunesen et al., 2010
  • 詳細 QPatch: the missing link between HTS and ion channel drug discovery.
    Year: 2009 First author: Mathes

Reports

  • 詳細 TRPM8 cold sensitive ion channels
    Year: 2012 First author: Jensen
  • 詳細 HEK293-TRPV1 on QPatch
    Year: 2011 First author: Jacobsen et al., 2011

P2X

Posters

  • 詳細 Development and validation of ligand-gated ion channel assays using the Qube 384 automated electrophysiology platform
    Year: 2019 First author: Marklew et Al., 2019
  • 詳細 Pharmacological characterization of voltage- and ligand-gated ion channels
    Year: 2006 First author: Olsen et al., 2006

Papers

  • 詳細 Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies
    Year: 2016 First author: Shcherbatko et al., 2016
  • 詳細 QPatch: the missing link between HTS and ion channel drug discovery.
    Year: 2009 First author: Mathes

Reports

  • 詳細 Validation of ligand-gated ion channels in multi-hole mode on QPatch
    Year: 2012 First author: Jacobsen et al., 2012
  • 詳細 CHO TREx-P2X3 on QPatch
    Year: 2008 First author: Schrøder et al., 2008

NMDA, AMPA and KA

Papers

  • 詳細 A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain
    Year: 2016 First author: Tabakoff et al., 2016
  • 詳細 Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content
    Year: 2016 First author: Ariasa et al., 2016

ASIC1-3

Posters

  • 詳細 Application of QPatch 16 for drug screening of ligand-gated ion channels
    Year: 2005 First author: Andersen et al., 2005
This page is optimized for desktops - please visit from a desktop-machine.